Related Experiment Videos
Cervical myelography using metrizamide and lateral C1-C2 approach.
1Department of Neuroradiology, Medical School, Hannover, Germany.
Acta Radiologica. Supplementum
|January 1, 1977
Summary
Metrizamide (Amipaque) introduced via a lateral C1-C2 approach provides excellent cervical myelography results. This technique clearly visualizes intraspinal anatomy and aids in detecting small lesions.
Area of Science:
- Radiology
- Neurology
- Medical Imaging
Background:
- Cervical myelography is crucial for diagnosing spinal cord and nerve root pathologies.
- Metrizamide (Amipaque) is a non-ionic contrast agent used in neuroradiology.
Purpose of the Study:
- To evaluate the efficacy of metrizamide (Amipaque) for cervical myelography.
- To assess the utility of a lateral C1-C2 injection approach for contrast delivery.
Main Methods:
- Cervical myelography was performed using metrizamide (Amipaque).
- Contrast was introduced via a lateral C1-C2 puncture approach.
- Radiographic imaging was used to evaluate the visualization of intraspinal structures.
Main Results:
- The lateral C1-C2 approach with metrizamide (Amipaque) yielded excellent results.
- Intraspinal anatomic structures were clearly and sharply outlined.
- Small intraspinal lesions were easily detected using this method.
Conclusions:
- The lateral C1-C2 approach is an effective method for cervical myelography with metrizamide (Amipaque).
- This technique offers superior visualization of cervical spinal anatomy and lesion detection.